Business Daily Media

The Times Real Estate

.

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

  • Written by PR Newswire
MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sustained limus release DEB catheter, in the...

More Articles ...

  1. DAZN Group Announces Appointment Of Kevin Mayer As Chairman Of The Board
  2. WellmarkerBio receives approval for Phase I clinical trial from the Australian Therapeutic Goods Administration
  3. LMRKTS Completes Successful Proof of Concept Simplifying ISDA SIMM Optimization
  4. J L Stream launches a 'Made in India' Social LIVE streaming app
  5. EZZ Life Science Holdings Limited to list on the ASX today following oversubscribed A$6m IPO
  6. Cattle Dog Digital Wins FinancialForce's APAC Partner of The Year 2021 Award
  7. Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand
  8. Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg)
  9. Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug
  10. Marriott International Pilots AI Solutions to Streamline Hotel Design Process for Future Properties in Asia-Pacific

Retailers combat post-Christmas debt and boost revenue amid changing customer behaviours

As the festive season wraps up, Australian retailers and companies are shifting their focus from holiday sales to addressing the challenges of pos...

When Will Infrastructure Companies See Gains from Generative AI?

A lot of questions are swirling about the state of generative AI right now. How far along are companies with their bespoke GenAI efforts? Are orga...

DLPA partners with Crestcom to bring its leadership training solutions

Dynamic Leadership Programs Australia (DLPA), a leading provider of leadership training and workforce strategy solutions, has joined forces with r...

Infosys and Tennis Australia Create New Generative AI Innovations at the Australian Open 2025

Infosys (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting, in partnership with Tennis Australia, has unv...

UBH Group Pioneers Australia's Path to Nuclear Sovereignty

Sovereign technology company, UBH Group, has achieved a landmark milestone as the first organisation in the Southern Hemisphere to secure ISO 1944...

The unsung heroes: How MSPs can safeguard SMBs while boosting profitability

In Australia, small-to-medium-sized businesses (SMBs) form the backbone of the economy, accounting for 95% of all businesses. Yet, they remain pri...

Sell by LayBy